Quick Takeaways
- This page summarizes Daniel J. Starks's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 28 Jul 2022, 17:20.
Daniel J. Starks - 26 Jul 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Role
- Director
- Signature
- /s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact
- Issuer symbol
- ABT
- Transactions as of
- 26 Jul 2022
- Net transactions value
- -$5,456,994
- Form type
- 4
- Filing time
- 28 Jul 2022, 17:20:11 UTC
- Previous filing
- 05 May 2022
- Next filing
- 31 Oct 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Daniel J. Starks filed Form 4 for ABBOTT LABORATORIES (ABT) on 28 Jul 2022."
What Changed
- Previous filing in this sequence was filed on 05 May 2022.
- Current net transaction value: -$5,456,994.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Sale | $3,018,175 | -27,749 | -0.4% | $108.77 | 6,945,751 | 26 Jul 2022 | Direct | F1 |
| transaction | ABT | Common shares without par value | Sale | $2,438,819 | -22,251 | -0.32% | $109.60 | 6,923,500 | 26 Jul 2022 | Direct | F2 |
| holding | ABT | Common shares without par value | 258 | 26 Jul 2022 | Alynne Starks 2012 Irrevocable Trust | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.32 to $109.31, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.33 to $109.85 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust. |
Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).